Anika Therapeutics Inc. (ANIK): Price and Financial Metrics

Anika Therapeutics Inc. (ANIK): $22.46

0.02 (-0.09%)

POWR Rating

Component Grades








Add ANIK to Watchlist
Sign Up

Industry: Biotech




#43 of 347

in industry

ANIK Price/Volume Stats

Current price $22.46 52-week high $32.33
Prev. close $22.48 52-week low $16.54
Day low $22.23 Volume 48,900
Day high $22.98 Avg. volume 118,350
50-day MA $20.15 Dividend yield N/A
200-day MA $23.46 Market Cap 328.84M

ANIK Stock Price Chart Interactive Chart >


  • ANIK scores best on the Value dimension, with a Value rank ahead of 76.94% of US stocks.
  • The strongest trend for ANIK is in Stability, which has been heading down over the past 177 days.
  • ANIK ranks lowest in Momentum; there it ranks in the 24th percentile.

ANIK Stock Summary

  • ANIKA THERAPEUTICS INC's stock had its IPO on May 4, 1993, making it an older stock than 79% of US equities in our set.
  • For ANIK, its debt to operating expenses ratio is greater than that reported by only 21.2% of US equities we're observing.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.21 for ANIKA THERAPEUTICS INC; that's greater than it is for merely 14.09% of US stocks.
  • If you're looking for stocks that are quantitatively similar to ANIKA THERAPEUTICS INC, a group of peers worth examining would be LVOX, NVVE, PRCT, RPID, and DIBS.
  • ANIK's SEC filings can be seen here. And to visit ANIKA THERAPEUTICS INC's official web site, go to

ANIK Valuation Summary

  • In comparison to the median Healthcare stock, ANIK's price/sales ratio is 2.7% lower, now standing at 1.8.
  • Over the past 243 months, ANIK's price/sales ratio has gone down 3.8.

Below are key valuation metrics over time for ANIK.

Stock Date P/S P/B P/E EV/EBIT
ANIK 2023-11-20 1.8 1.1 -12.3 -8.6
ANIK 2023-11-17 1.9 1.1 -12.5 -8.8
ANIK 2023-11-16 1.9 1.1 -12.5 -8.8
ANIK 2023-11-15 1.8 1.1 -12.2 -8.6
ANIK 2023-11-14 1.9 1.1 -12.6 -8.9
ANIK 2023-11-13 1.8 1.1 -12.1 -8.5

ANIK Growth Metrics

    Its year over year price growth rate is now at -49.93%.
  • Its year over year cash and equivalents growth rate is now at -4.52%.
  • Its year over year revenue growth rate is now at 16.11%.
ANIK's revenue has moved up $44,448,000 over the prior 49 months.

The table below shows ANIK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 152.435 8.4 -15.744
2022-06-30 151.707 7.753 -11.011
2022-03-31 150.195 8.959 -1.637
2021-12-31 147.794 8.397 4.134
2021-09-30 144.661 6.512 -5.729
2021-06-30 136.819 10.315 -12.698

ANIK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ANIK has a Quality Grade of B, ranking ahead of 75.55% of graded US stocks.
  • ANIK's asset turnover comes in at 0.363 -- ranking 122nd of 186 Medical Equipment stocks.
  • SYK, EYE, and ISRG are the stocks whose asset turnover ratios are most correlated with ANIK.

The table below shows ANIK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.363 0.555 -0.097
2021-03-31 0.326 0.532 -0.187
2020-12-31 0.322 0.529 -0.144
2020-12-31 0.322 0.529 -0.144
2020-09-30 0.322 0.576 -0.027
2020-06-30 0.337 0.636 0.076

ANIK Price Target

For more insight on analysts targets of ANIK, see our ANIK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $49.67 Average Broker Recommendation 1.33 (Strong Buy)

Anika Therapeutics Inc. (ANIK) Company Bio

Anika Therapeutics develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. The company was founded in 1983 and is based in Bedford, Massachusetts.

ANIK Latest News Stream

Event/Time News Detail
Loading, please wait...

ANIK Latest Social Stream

Loading social stream, please wait...

View Full ANIK Social Stream

Latest ANIK News From Around the Web

Below are the latest news stories about ANIKA THERAPEUTICS INC that investors may wish to consider to help them evaluate ANIK as an investment opportunity.

Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release

Integrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic acid (HA) regenerative portfolio BEDFORD, Mass., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that the first surgeries using the Integrity Implant System were successfully performed by Dr. Christopher Baker at the Florida O

Yahoo | November 28, 2023

Anika to Participate in Upcoming Investor Conferences

BEDFORD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following investor conferences: The Stephens Annual Investment Conference at the Grand Hyatt, Nashville, TN, on Wednesday, November 15, 2023. T

Yahoo | November 7, 2023

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good evening, ladies and gentlemen, and welcome to Anika’s Third Quarter 2023 Earnings Conference Call. All participants’ will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note today’s event […]

Yahoo | November 5, 2023

Q3 2023 Anika Therapeutics Inc Earnings Call

Q3 2023 Anika Therapeutics Inc Earnings Call

Yahoo | November 3, 2023

Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year Guidance

Joint Preservation and Restoration revenue up 14%, OA Pain Management revenue up 2% in Q3 2023

Yahoo | November 2, 2023

Read More 'ANIK' Stories Here

ANIK Price Returns

1-mo 10.15%
3-mo 29.75%
6-mo -18.77%
1-year -26.70%
3-year -41.13%
5-year -29.30%
YTD -24.12%
2022 -17.39%
2021 -20.84%
2020 -12.71%
2019 54.27%
2018 -37.66%

Continue Researching ANIK

Here are a few links from around the web to help you further your research on Anika Therapeutics Inc's stock as an investment opportunity:

Anika Therapeutics Inc (ANIK) Stock Price | Nasdaq
Anika Therapeutics Inc (ANIK) Stock Quote, History and News - Yahoo Finance
Anika Therapeutics Inc (ANIK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!